Single-Center Contemporary Clinical Outcomes after Endovascular Treatment in Patients with De Novo Femoropopliteal Lesions between 2017 and 2019-Reference-Cited by-同舟云学术

Single-Center Contemporary Clinical Outcomes after Endovascular Treatment in Patients with De Novo Femoropopliteal Lesions between 2017 and 2019

Published:2023-03-25 Issue:1 Volume:16 Page:38-45
ISSN:1881-641X
Container-title:Annals of Vascular Diseases
language:en
Short-container-title:Annals of Vascular Diseases

Author:

Horie Kazunori¹,Tanaka Akiko¹,Taguri Masataka²,Tada Norio¹

Affiliation:

1. Department of Cardiovascular Medicine, Sendai Kousei Hospital

2. Department of Health Data Science, Tokyo Medical University

Publisher

The Editorial Committee of Annals of Vascular Diseases

Subject

Pharmaceutical Science

Link

https://www.jstage.jst.go.jp/article/avd/16/1/16_oa.22-00081/_pdf

Reference23 articles.

1. 1) Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper, and lower extremity arteries Endorsed by: The European Stroke Organization (ESO), the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39: 763-816.

2. 2) Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015; 131: 495-502.

3. 3) Schneider PA, Laird JR, Tepe G, et al. treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv 2018; 11: e005891.

4. 4) Ansel GM, Brodmann M, Keirse K, et al. Drug-coated balloon treatment of femoropopliteal lesions typically excluded from clinical trials: 12-month findings from the IN.PACT global study. J Endovasc Ther 2018; 25: 673-82.

5. 5) Ding Y, Zhou M, Wang Y, et al. comparison of drug-eluting stent with bare-metal stent implantation in femoropopliteal artery disease: a systematic review and meta-analysis. Ann Vasc Surg 2018; 50: 96-105.